Hideo Yagita∥

Researcher Next ID · RN-004780

Researcher · Immunology and Microbiology

Tokyo, Japan

Not currently recruitingFunding unknown

Research interests

Immunology and Microbiology

Medicine

Immune Cell Function and Interaction

Immunotherapy and Immune Responses

T-cell and B-cell Immunology

Cancer Immunotherapy and Biomarkers

CAR-T cell therapy research

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
The Journal of Experimental Medicine · 2015 · https://doi.org/10.1084/jem.20140559
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
The Journal of Experimental Medicine · 2013 · https://doi.org/10.1084/jem.20130579
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Proceedings of the National Academy of Sciences · 2010 · https://doi.org/10.1073/pnas.0915174107
ATP drives lamina propria TH17 cell differentiation
Nature · 2008 · https://doi.org/10.1038/nature07240
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
International Immunology · 1996 · https://doi.org/10.1093/intimm/8.5.765

No projects listed.